News

Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia

Updated Phase 1 data presented at ESH-iCMLf 26th Annual John Goldman Conference Reported cumulative MMR rate of 44% (8/18) by…

1 year ago

GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease

GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary…

1 year ago

Next Health Announces Proactive Healthcare and Longevity Centers Coming Soon to Tampa and St. Petersburg

TAMPA, Fla.--(BUSINESS WIRE)--#cryotherapy--Next Health, the world's most advanced brand of proactive healthcare centers, is bringing two health optimization and longevity…

1 year ago

Quantum Biopharma Provides Corporate Update

TORONTO, ON / ACCESSWIRE / September 27, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or…

1 year ago

Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting

Visit Covalon at booth 523 to discover the latest in compassionate vascular access solutions MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the…

1 year ago

New Published Data Show Reproducibility and Utility of Perspectum’s MRI in Patients With Metabolic Liver Disease

WASHINGTON & OXFORD, England--(BUSINESS WIRE)--#Healthcare--Perspectum announced two research studies that were recently published, bringing hope to people with metabolic dysfunction-associated…

1 year ago

111, Inc. Announces Receipt of Notification from Nasdaq

SHANGHAI, Sept. 27, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed…

1 year ago

Raintree Systems Accelerates Innovation and Growth with Strategic Appointment to Board of Directors

30-Year Tech and Healthcare Veteran, Bill Lucchini, to Advise on Driving Customer Value Through Automation and Efficiency CHANDLER, Ariz., Sept.…

1 year ago

POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM)

BUFFALO, NY / ACCESSWIRE / September 27, 2024 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical company, is pleased…

1 year ago

MasterWord and UNESCO Join Forces to Preserve and Digitize Mayan Languages for Future Generations

HOUSTON, TX / ACCESSWIRE / September 27, 2024 / MasterWord is honored to announce its partnership with UNESCO, within its…

1 year ago